Amarantus Bioscience wraps $125,000 of $2 million preferreds issuance

Company sells 125 series G convertible preferreds in second tranche

By Devika Patel

Knoxville, Tenn., July 15 – Amarantus Bioscience Holdings, Inc. raised $125,000 in a $2 million sale of its series G convertible preferred stock on July 13, according to an 8-K filed Wednesday with the Securities and Exchange Commission. It raised $1 million on July 9.

The company sold 125 preferreds in the latest tranche.

The biotechnology company is based in Sunnyvale, Calif.

Issuer:	Amarantus Bioscience Holdings, Inc.
Issue:	Series G convertible preferred stock
Amount:	$2 million
Price:	$1,000.00
Warrants:	No
Settlement dates:	July 9 (for $1 million), July 13 (for $125,000)
Stock symbol:	Nasdaq: AMBS
Stock price:	$0.05 at close July 8
Market capitalization:	$36.75 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.